Satralizumab
Records for this ingredient, by country (identity only).
ATC L04AC19 · 11 markets · 13 records
AU 2 records · 1 shown of 1
- 120 mg per mL / per unit basis not statedinjectionENSPRYNG satralizumab 120 mg/1 mL solution for injection in pre-filled syringe
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 2 records · 1 shown of 1
- 120 mg/1 mLinjectionエンスプリング皮下注120mgオートインジェクターエンスプリング皮下注120mgシリンジ
US 1 records · 1 shown of 1
- 120 mg per mL / per unit basis not statedinjectionEnspryng
GB 1 records · 1 shown of 1
- 120 mg/1 mLinjectionEnspryng 120mg/1ml solution for injection pre-filled syringes
CA 1 records · 1 shown of 1
- 120 mg per mL / per unit basis not statedliquidEnspryng
SG 1 records · 1 shown of 1
- 120 mg/mL per mL / per unit basis not statedinjectionENSPRYNG SOLUTION FOR INJECTION IN PREFILLED SYRINGE 120MG/1ML
ES 1 records · 1 shown of 1
- 120 mg per mL / per unit basis not statedinjectionENSPRYNG PRECARGADA
TW 1 records · 1 shown of 1
- 120 mg per mL / per unit basis not statedinjectionENSPRYNG 120 mg for SC櫻普立皮下注射劑120毫克
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 shown of 1
- 120 mg/1 mLinjectionENSPRYNG 120 mg, solution injectable en seringue préremplie
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | JP | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 120 mg per mL / per unit basis not stated cannot compare injection | Enspryng | ENSPRYNG satralizumab 120 mg/1 mL solution for injection in pre-filled syringe | ENSPRYNG PRECARGADA | ENSPRYNG 120 mg for SC 櫻普立皮下注射劑120毫克 | |||||||
| 120 mg/1 mL injection | Enspryng 120mg/1ml solution for injection pre-filled syringes | エンスプリング皮下注120mgオートインジェクター エンスプリング皮下注120mgシリンジ | ENSPRYNG 120 mg, solution injectable en seringue préremplie | ||||||||
| 120 mg per mL / per unit basis not stated cannot compare liquid | Enspryng | ||||||||||
| 120 mg/mL per mL / per unit basis not stated cannot compare injection | ENSPRYNG SOLUTION FOR INJECTION IN PREFILLED SYRINGE 120MG/1ML | ||||||||||
unknown | Enspryng | ENSPRYNG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 120MG/1ML | Enspryng |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in CA · SG and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · SG que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · SG 有记录（未在本表显示）。 另有 2 個規格/劑型僅在 CA · SG 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.